Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
4
×
boston blog main
boston top stories
drugs
4
×
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
4
×
clinical trials
san diego blog main
san diego top stories
akcea therapeutics
alnylam pharmaceuticals
biotech
hereditary transthyretin amyloidosis
inotersen
patisiran
san francisco blog main
san francisco top stories
tafamidis
allopregnanolone
antibiotics
arvinas
astrazeneca
barry greene
boston university
boulder/denver
boulder/denver blog main
boulder/denver top stories
brexanolone
carbapenem-resistant enterobacteriaceae
celgene
dan ollendorf
detroit
detroit blog main
detroit top stories
entasis therapeutics
european medicines agency
What
fda
medicine
alnylam
drug
make
rna
uses
way
ago
approve
approved
approves
awaits
biological
biotechs
brexanolone
cells
chose
close
company
crossed
decades
decision
depression
devastating
device
discovered
disorder
ema
employ
europe
fast
fingers
firms
follows
friday
gene
harmful
historic
hits
Language
Current search:
drugs
×
boston
×
" new york top stories "
×
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision